National Bank of Canada’s INmune Bio INMB Stock Holding History

National Bank of Canada’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.28K	Buy	+2,000	New	+$2.77K	﹤0.01%	2637
2025 Q4	–	Sell	-200	Closed	-$412	–	3006
2025 Q3	$412	Sell	200 -92,100	-100%	-$211K	﹤0.01%	2706
2025 Q2	$213K	Buy	92,300 +52,800	+134%	+$387K	﹤0.01%	1594
2025 Q1	$308K	Buy	39,500 +39,300	+19,650%	+$312K	﹤0.01%	1429
2024 Q4	$934	Buy	+200	New	+$1.04K	﹤0.01%	2654

Other funds holding INMB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

National Bank of Canada's INMB Position: Q2 2026 in Review

National Bank of Canada opened a new position in INmune Bio (INMB) in Q2 2026: 2,000 shares worth $3.28K. The stake represents ﹤0.01% of the portfolio and ranks #2637 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in INMB as recently as Q3 2025.

National Bank of Canada first reported a position in INMB in Q4 2024 and has held it in 5 quarters since. The position peaked at $308K in Q1 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

National Bank of Canada held 2,000 shares of INmune Bio worth $3.28K as of Q2 2026.
INmune Bio was a new National Bank of Canada position in Q2 2026.
INmune Bio made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2637 holding.
National Bank of Canada first reported a position in INmune Bio in Q4 2024 and has held it in 5 quarters since.
National Bank of Canada's INmune Bio position peaked at $308K in Q1 2025.
82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.